Literature DB >> 35719778

POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, and Skin Changes): A Case Report of a Rare Paraneoplastic Syndrome.

Anuradha Sakhuja1, Dhan B Shrestha1, Wasey Ali Yadullahi Mir1, Suman Gaire2, Mohammed Kassem3.   

Abstract

POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes) syndrome is a multisystem disorder. Peripheral neuropathy and monoclonal plasma cell disorder are the most common manifestations of POEMS. Although osteosclerotic or mixed sclerotic-lytic lesions are typical, osteolytic lesions are rarely encountered. We present a case of a 39-year-old male with a history of multiple endocrine disorders who presented with paresthesia, edema, and hyperpigmentation and was eventually diagnosed with POEMS syndrome. Patients with unexplained neuropathy should be evaluated for POEMS syndrome, especially when it is associated with other findings like endocrinopathy, organomegaly, skin changes, or edema.
Copyright © 2022, Sakhuja et al.

Entities:  

Keywords:  hyperpigmentation; osteosclerosis; paraproteinemias; poems syndrome; polyneuropathy

Year:  2022        PMID: 35719778      PMCID: PMC9188846          DOI: 10.7759/cureus.24980

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  12 in total

1.  The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome.

Authors:  Anita D'Souza; Suzanne R Hayman; Francis Buadi; Michelle Mauermann; Martha Q Lacy; Morie A Gertz; Robert A Kyle; Shaji Kumar; Philip R Greipp; John A Lust; Stephen J Russell; Steven Zeldenrust; David Dingli; Thomas E Witzig; S Vincent Rajkumar; Angela Dispenzieri
Journal:  Blood       Date:  2011-08-31       Impact factor: 22.113

Review 2.  POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management.

Authors:  Angela Dispenzieri
Journal:  Am J Hematol       Date:  2011-07       Impact factor: 10.047

3.  POEMS syndrome: definitions and long-term outcome.

Authors:  Angela Dispenzieri; Robert A Kyle; Martha Q Lacy; S Vincent Rajkumar; Terry M Therneau; Dirk R Larson; Philip R Greipp; Thomas E Witzig; Rita Basu; Guillermo A Suarez; Rafael Fonseca; John A Lust; Morie A Gertz
Journal:  Blood       Date:  2002-11-27       Impact factor: 22.113

4.  [Increased vascular endothelial growth factor (VEGF) is causative in Crow-Fukase syndrome].

Authors:  K Arimura
Journal:  Rinsho Shinkeigaku       Date:  1999-01

5.  POEMS syndrome: report on six patients with unusual clinical signs, elevated levels of cytokines, macrophage involvement and chromosomal aberrations of bone marrow plasma cells.

Authors:  C Rose; M Zandecki; M C Copin; P Gosset; M Labalette; P Y Hatron; M O Jauberteau; B Devulder; F Bauters; T Facon
Journal:  Leukemia       Date:  1997-08       Impact factor: 11.528

6.  A case of atypical POEMS syndrome without polyneuropathy.

Authors:  Ryuji Morizane; Hiroyuki Sasamura; Hitoshi Minakuchi; Yujiro Takae; Haruhito Kikuchi; Naomi Yoshiya; Akinori Hashiguchi; Konosuke Konishi; Shinichiro Okamoto; Hiroshi Itoh
Journal:  Eur J Haematol       Date:  2008-02-13       Impact factor: 2.997

7.  The Crow-Fukase syndrome: a study of 102 cases in Japan.

Authors:  T Nakanishi; I Sobue; Y Toyokura; H Nishitani; Y Kuroiwa; E Satoyoshi; T Tsubaki; A Igata; Y Ozaki
Journal:  Neurology       Date:  1984-06       Impact factor: 9.910

8.  Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature.

Authors:  P A Bardwick; N J Zvaifler; G N Gill; D Newman; G D Greenway; D L Resnick
Journal:  Medicine (Baltimore)       Date:  1980-07       Impact factor: 1.889

9.  Outcomes of patients with POEMS syndrome treated initially with radiation.

Authors:  Michael S Humeniuk; Morie A Gertz; Martha Q Lacy; Robert A Kyle; Thomas E Witzig; Shaji K Kumar; Prashant Kapoor; John A Lust; Suzanne R Hayman; Francis K Buadi; S Vincent Rajkumar; Steven R Zeldenrust; Stephen J Russell; David Dingli; Yi Lin; Nelson Leung; Angela Dispenzieri
Journal:  Blood       Date:  2013-05-22       Impact factor: 22.113

10.  Efficacy and Safety of Regimens Used for the Treatment of POEMS Syndrome- A Systematic Review.

Authors:  Unaiza Faizan; Muhammad Khawar Sana; Muhammad Saad Farooqi; Hamza Hashmi
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2021-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.